Amyloid-busting drug for early Alzheimer’s fails to stop cognitive decline, long-term study concludes
By
Alicia Lasek
Jun 21, 2022
The failure of a more-than-decade-long trial in patients with early-onset Alzheimer’s deals yet another blow to a key treatment theory, observers say.
Come on, just diagnose it
By
Jacqueline Vance, RNC, CDONA/LTC
Jun 07, 2022
For some reason, it seems like practitioners run away from diagnosing people with Alzheimer’s disease. I don’t understand that when, in fact, Alzheimer’s disease accounts for 75% to 80% of all dementias. ...
After leading in COVID-19 drug trials, a nursing home chain now partners on dementia drug
By
Kimberly Marselas
May 31, 2022
Principle LTC, operator of 45 nursing homes in the Southeast, is building on its successful role in testing a key drug for COVID-19 prevention and treatment to launch trials of a new Alzheimer drug.
One in three Alzheimer, dementia cases tied to modifiable risk factors
May 11, 2022
Midlife obesity, physical inactivity and low education are three prominent modifiable risk factors tied to dementia, researchers say.
MA enrollees with dementia report poor quality of care: study
By
Alicia Lasek
May 09, 2022
Medicare Advantage plans will be more incentivized to address gaps in care if consumer care assessments include more input from enrollees with dementia, investigators say.
‘Magic tables’ provide stimulation for memory care residents
By
Kimberly Bonvissuto
May 06, 2022
Table top gaming consoles — so-called magic tables — are taking off in memory care communities, providing an easy way to stimulate the brains of those with memory impairing diseases.
Community burden of dementia symptoms mirrors that of nursing homes, caregiver survey finds
By
Alicia Lasek
Apr 29, 2022
Frequent, unsubtle symptoms have a big impact on patient quality of life, but are often unreported in primary care, investigators report.
Study: Healthy lifestyle adds to longevity, but not for Alzheimer’s patients
By
Diane Eastabrook
Apr 19, 2022
A healthy lifestyle can go a long way to adding years to your life, but it might not help those with Alzheimer’s disease and dementia.
Clinical briefs for Friday, April 15
By
Alicia Lasek
Apr 15, 2022
To boost or not to boost: Providers tackle the question … Exercise may protect against brain volume loss due to aging, investigators say … FDA delays REGEN-COV approval decision to July … U.S. economic...
CMS restricts coverage of Alzheimer’s drug Aduhelm to clinical trials
By
Alicia Lasek
Apr 08, 2022
Coverage of aducanumab (Aduhelm) is officially limited to clinical trials only, the agency announced Thursday. Most stakeholders have called for restricted use while more efficacy and safety data is gathered,...